Weiss Amir

Chief Accounting OfficerTEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) · full profile →Form 4 · filed Aug 25, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$355K
Net Open-Market Flow
-$355K
Transactions
4
3 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 21, 2026Sell(S)7K$37.61$261K13K
Aug 21, 2026Option exercise(M)3K$19.61$49K16K
Aug 21, 2026Sell(S)3K$37.63$94K13K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Aug 21, 2026Option exercise(M)3K$19.16$48K8K

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-26-365116) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

Build

Build on these Form 4 transactions

The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.